30 results
IDSA Aspergillosis Treatment
 • Invasive pulmonary aspergillosis (IPA)
 • CNS aspergillosis
 • Cardiac Aspergillus infection
 •
IDSA Aspergillosis ... Treatment • Invasive ... pulmonary aspergillosis ... #management #pharmacology ... #IDSA
IDSA Treatment of Necrotizing Infections of the Skin, Fascia, and Muscle
 • Mixed infections
 • Streptococcus
IDSA Treatment of ... Necrotizing Infections ... fasciitis #Skin #IDSA ... #Treatment #management ... #antibiotics #pharmacology
IDSA - Antimicrobial Therapy for Staphylococcal and Streptococcal Skin and Soft Tissue Infections
 • Impetigo (Staphylococcus
IDSA - Antimicrobial ... and Soft Tissue Infections ... Streptococcal #Antibiotics ... #management #treatment ... #idsa #cellulitis
IDSA Surgical Wound Infection Algorithm
Algorithm for the management and treatment of surgical site infections (SSIs). 
*For
IDSA Surgical Wound ... Algorithm for the management ... and treatment of ... allergy to β-lactam antibiotics ... #Algorithm #IDSA
Outpatient Treatment of with Community-Acquired Pneumonia (CAP)
No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
Outpatient Treatment ... with Community-Acquired ... fluoroquinolone #IDSA ... #Pneumonia #Antibiotics ... #Management #Guidelines
IDSA Algorithm for the Management of Purulent skin and soft tissue infections (SSTIs). 
Mild infection: for
IDSA Algorithm for ... the Management ... drainage plus oral antibiotics ... treatment or those ... #cellulitis #idsa
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
Diagnosis and Management ... can be community-acquired ... (IDSA 2021): ... /severe CDI IDSA ... 2021 CDI Treatment
Aplastic Anemia - Illness Script
Signs and symptoms:
 • Recurrent infections from neutropenia
 • Mucosal bleeding from
: • Recurrent infections ... megaloblastic anemia Treatment ... (transfusions, antibiotics ... Anemia #diagnosis #management ... #treatment #hematology
IDSA 2017 CDiff Guidelines - Table 7. Potential Treatment Agents for Treatment of the Primary Clostridium difficile
IDSA 2017 CDiff ... Potential Treatment ... Clostridium difficile infection ... #Pharmacology #Management ... IDSA2017 #Adjunct #Antibiotics
Hemophagocytic Lymphohistiocytosis (HLH)
Pathophysiology: Triggering factor (infection,...)→Activation of CD8 T cells (IFN-y) → Excessive activation of macrophages
Purtilo (XLP) Acquired ... Unknown cause Treatment ... Lymphohistiocytosis #diagnosis #management ... #treatment #summary ... #rheumatology